Synacthen (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 78 | 下垂体前葉機能低下症 | 3 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00851942 (ClinicalTrials.gov) | September 2008 | 25/2/2009 | Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test | Determination of Method-specific Normal Cortisol and Adrenal Hormone Responses to the Short Synacthen Test | Healthy;Adrenal Insufficiency;Hypopituitarism | Drug: Synacthen (Tetracosactrin) | Cardiff University | NULL | Completed | 18 Years | 80 Years | All | 165 | Phase 4 | United Kingdom |
| 2 | EUCTR2007-000056-14-GB (EUCTR) | 03/03/2008 | 04/01/2008 | Determination of method-specific normal cortisol and adrenal hormone responses to the short Synacthen test - Short Synacthen test Study | Determination of method-specific normal cortisol and adrenal hormone responses to the short Synacthen test - Short Synacthen test Study | Normal, healthy volunteers to establish a reference range for the synacthen test, plus patients with hypoadrenalism/hypopituitarism MedDRA version: 9.1;Level: LLT;Classification code 10020936;Term: Hypoadrenalism MedDRA version: 9.1;Classification code 10021067;Term: Hypopituitarism | Cardiff University | NULL | Not Recruiting | Female: yes Male: yes | 240 | Phase 4 | United Kingdom | |||
| 3 | NCT00552487 (ClinicalTrials.gov) | October 2005 | 31/10/2007 | Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis | Isolated ACTH Deficiency in Patients With Hashimoto Thyroiditis | Hashimoto Disease;Adrenal Insufficiency | Drug: synacthen | University of Wuerzburg | NULL | Completed | 18 Years | N/A | Both | 62 | N/A | Germany |